Related Experiment Videos
[Amikacin concentration in the severely obstructed urinary tract]
Hinyokika Kiyo. Acta Urologica Japonica
|August 1, 1984
Summary
Urinary amikacin levels in obstructed kidneys may suffice for prophylaxis. However, treating active infections in these cases requires higher intravenous amikacin doses (at least 200 mg).
Area of Science:
- Pharmacology
- Nephrology
- Urology
Context:
- Severely unilateral ureteral obstruction can impact drug pharmacokinetics.
- Understanding antibiotic concentrations in urine is crucial for effective treatment.
- Amikacin is an antibiotic commonly used for serious infections.
Purpose:
- To determine urinary amikacin concentrations in patients with severe unilateral ureteral obstruction.
- To compare amikacin levels in obstructed versus normal urinary tracts.
- To provide dosing recommendations for amikacin in obstructed urinary systems.
Summary:
- Urinary amikacin concentrations were measured in 9 patients with severe unilateral ureteral obstruction following intravenous infusion.
- The average concentration in the obstructed tract was 118.9 mcg/ml at 6 hours, while the normal kidney showed concentrations of 155.9, 98.8, and 83.3 mcg/ml over 6 hours.
- Urinary excretion from the obstructed tract was approximately one-third of that from a normal system.
Impact:
- Findings suggest that 100 mg of intravenous amikacin may offer prophylactic urinary levels in obstructed tracts.
- Higher doses (≥200 mg IV) are recommended for treating active infections in severely obstructed urinary tracts.
- This research aids in optimizing amikacin dosing strategies for patients with ureteral obstruction.